Stocks Overview

LAST PRICE
22.3700
TODAY'S CHANGE (%)
Trending Down-0.4600 (-2.0149%)

Bid / Lots
22.2200/ 1
Ask / Lots
22.5000/ 10
Open / Previous Close
22.6400 / 22.8300
Day Range
Low 22.0200
High 22.7800
52 Week Range
Low 6.4600
High 26.4100
Volume
1,882,545
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Tuesday's close: 22.83
Time	Volume	TGTX
09:32 ET	17261	22.6599
09:34 ET	13212	22.44
09:36 ET	7044	22.46
09:38 ET	20214	22.425
09:39 ET	14728	22.295
09:41 ET	38571	22.245
09:43 ET	19287	22.195
09:45 ET	49416	22.1
09:48 ET	15910	22.085
09:50 ET	51842	22.175
09:52 ET	13243	22.312
09:54 ET	13782	22.32
09:56 ET	6300	22.33
09:57 ET	6721	22.32
09:59 ET	9257	22.36
10:01 ET	28484	22.25
10:03 ET	2686	22.29
10:06 ET	6555	22.335
10:08 ET	11971	22.355
10:10 ET	5534	22.43
10:12 ET	4734	22.63
10:14 ET	5870	22.525
10:15 ET	26861	22.38
10:17 ET	16413	22.34
10:19 ET	8300	22.444
10:21 ET	4645	22.48
10:24 ET	1578	22.4
10:26 ET	3742	22.385
10:28 ET	1500	22.5
10:30 ET	3000	22.46
10:32 ET	997	22.47
10:33 ET	2700	22.49
10:35 ET	4150	22.44
10:37 ET	1400	22.42
10:39 ET	3449	22.44
10:42 ET	5065	22.52
10:44 ET	17873	22.58
10:46 ET	10068	22.568
10:48 ET	1961	22.57
10:50 ET	5350	22.59
10:51 ET	4651	22.64
10:53 ET	7454	22.56
10:55 ET	5637	22.58
10:57 ET	2000	22.52
11:00 ET	6276	22.48
11:02 ET	11639	22.51
11:04 ET	4293	22.5375
11:06 ET	3675	22.63
11:08 ET	9343	22.59
11:09 ET	3075	22.53
11:11 ET	1205	22.51
11:13 ET	4035	22.505
11:15 ET	1308	22.53
11:18 ET	1756	22.54
11:20 ET	2050	22.56
11:22 ET	4065	22.58
11:24 ET	1900	22.51
11:26 ET	2298	22.49
11:27 ET	3568	22.54
11:29 ET	2500	22.56
11:31 ET	4138	22.56
11:33 ET	8857	22.53
11:36 ET	1556	22.56
11:38 ET	2097	22.57
11:40 ET	4027	22.53
11:42 ET	4180	22.5
11:44 ET	600	22.52
11:45 ET	3790	22.55
11:47 ET	4426	22.58
11:49 ET	1299	22.575
11:51 ET	6464	22.58
11:54 ET	1361	22.58
11:56 ET	18203	22.68
11:58 ET	3155	22.65
12:00 ET	5309	22.55
12:02 ET	8203	22.605
12:03 ET	20029	22.68
12:05 ET	10614	22.66
12:07 ET	3041	22.6453
12:09 ET	6849	22.68
12:12 ET	62736	22.58
12:14 ET	9900	22.6
12:16 ET	5745	22.5613
12:18 ET	25906	22.45
12:20 ET	5311	22.48
12:21 ET	1182	22.473
12:23 ET	3833	22.486704
12:25 ET	4127	22.54
12:27 ET	5111	22.59
12:30 ET	2136	22.62
12:32 ET	2831	22.6
12:34 ET	757	22.6034
12:36 ET	1421	22.605
12:38 ET	3389	22.62
12:39 ET	2487	22.61
12:41 ET	3370	22.64
12:43 ET	5090	22.605
12:45 ET	600	22.6
12:48 ET	676	22.61
12:50 ET	2159	22.61
12:52 ET	2417	22.58
12:54 ET	800	22.58
12:56 ET	2920	22.555
12:57 ET	1420	22.52
12:59 ET	605	22.48
01:01 ET	1824	22.47
01:03 ET	3123	22.42
01:06 ET	40274	22.35
01:08 ET	2200	22.36
01:10 ET	11551	22.4
01:12 ET	2900	22.39
01:14 ET	6198	22.35
01:15 ET	3657	22.31
01:17 ET	500	22.33
01:19 ET	1510	22.31
01:21 ET	3491	22.33
01:24 ET	2101	22.35
01:26 ET	3470	22.34
01:28 ET	6748	22.42
01:30 ET	24179	22.45
01:32 ET	2593	22.365
01:33 ET	6886	22.34
01:35 ET	4847	22.32
01:37 ET	3673	22.355
01:39 ET	4295	22.37
01:42 ET	1480	22.36
01:44 ET	3711	22.36
01:46 ET	2200	22.35
01:48 ET	3090	22.38
01:50 ET	1100	22.39
01:51 ET	1932	22.42
01:53 ET	1540	22.43
01:55 ET	3841	22.45
01:57 ET	2210	22.38
02:00 ET	4242	22.44
02:02 ET	1854	22.468
02:04 ET	8106	22.47
02:06 ET	1632	22.48
02:08 ET	12374	22.4902
02:09 ET	950	22.5
02:11 ET	1200	22.51
02:13 ET	4721	22.48
02:15 ET	3555	22.42
02:18 ET	3250	22.41
02:20 ET	700	22.4157
02:22 ET	1885	22.43
02:24 ET	1802	22.43
02:26 ET	7055	22.43
02:27 ET	1912	22.42
02:29 ET	4567	22.38
02:31 ET	6959	22.4
02:33 ET	1700	22.42
02:36 ET	2913	22.435
02:38 ET	1920	22.45
02:40 ET	2263	22.44
02:42 ET	1000	22.44
02:44 ET	4401	22.455
02:45 ET	1300	22.45
02:47 ET	4249	22.44
02:49 ET	2220	22.44
02:51 ET	1335	22.425541
02:54 ET	6500	22.35
02:56 ET	7099	22.35
02:58 ET	1300	22.36
03:00 ET	3411	22.32
03:02 ET	3397	22.3324
03:03 ET	5561	22.35
03:05 ET	1749	22.36
03:07 ET	4707	22.35
03:09 ET	1484	22.375
03:12 ET	4649	22.37
03:14 ET	6378	22.36
03:16 ET	4014	22.38
03:18 ET	2386	22.38
03:20 ET	2932	22.36
03:21 ET	5226	22.385
03:23 ET	2178	22.37
03:25 ET	4277	22.33
03:27 ET	2903	22.325
03:30 ET	3825	22.36
03:32 ET	2398	22.35
03:34 ET	1000	22.355
03:36 ET	4149	22.36
03:38 ET	2723	22.36
03:39 ET	3270	22.31
03:41 ET	4502	22.34
03:43 ET	6362	22.365
03:45 ET	3781	22.385
03:48 ET	5343	22.385
03:50 ET	4305	22.42
03:52 ET	16391	22.425
03:54 ET	16485	22.385
03:56 ET	12196	22.385
03:57 ET	23011	22.425
03:59 ET	216331	22.37

Data delayed at least 15 minutes.

Sep 18, 2024
- DJ TG Therapeutics Price Target Maintained With a $49.00/Share by HC Wainwright & Co., from 1:12PM ET on Wednesday Sep 18, 2024 by Dow Jones
  1:12PM ET on Wednesday Sep 18, 2024 by Dow Jones
- New BRIUMVI(R) (ublituximab-xiiy) Data from the ENHANCE Phase 3b Study Show Rapid 30-Minute Infusions are Well Tolerated in Patients with Relapsing Forms of Multiple Sclerosis, from 7:15AM ET on Wednesday Sep 18, 2024 by Dow Jones
  7:15AM ET on Wednesday Sep 18, 2024 by Dow Jones
- New Data for BRIUMVI(R) (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment, from 7:00AM ET on Wednesday Sep 18, 2024 by Dow Jones
  7:00AM ET on Wednesday Sep 18, 2024 by Dow Jones
Sep 6, 2024
- Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600, from 6:43PM ET on Friday Sep 06, 2024 by Dow Jones
  6:43PM ET on Friday Sep 06, 2024 by Dow Jones
Sep 5, 2024
- TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting, from 7:30AM ET on Thursday Sep 05, 2024 by Dow Jones
  7:30AM ET on Thursday Sep 05, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesTGTX TG Therapeutics Inc	3.5B	37.3x	---
United StatesALVO Alvotech SA	3.6B	-4.6x	---
United StatesAXSM Axsome Therapeutics Inc	4.3B	-14.3x	---
United StatesTWST Twist Bioscience Corp	2.5B	-11.3x	---
United StatesARWR Arrowhead Pharmaceuticals Inc	2.4B	-4.1x	---
United StatesDNLI Denali Therapeutics Inc	4.1B	-10.2x	---
As of 2024-10-03

TG Therapeutics, Inc. is a fully integrated, commercial stage, biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its clinical drug candidates include Ublituximab (anti-CD20 mAb), TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb). BRIUMVI is an anti-CD20 monoclonal antibody for the treatment of RMS, which include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TG-1701 is a novel, orally available and covalently bound Bruton’s tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in in vitro kinase screening. TG-1801 is a bispecific CD47 and CD19 antibody. It is the therapy to target both CD19, a B-cell specific market expressed across B-cell malignancies, and CD47. It also evaluates complementary products, technologies and companies for in-licensing, partnership, acquisition and/or investment opportunities.

Contact Information

Headquarters: 3020 Carrington Mill Blvd., Suite 475MORRISVILLE, NC, United States 27560-5435
Phone: 212-554-4484
Fax: 212-554-4531

Executives

Chairman of the Board, President, Chief Executive Officer: Michael Weiss
Chief Financial Officer, Treasurer, Corporate Secretary: Sean Power
Lead Independent Director: Laurence Charney
Independent Director: Yann Echelard
Independent Director: Kenneth Hoberman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$3.5B
Revenue (TTM)	$346.7M
Shares Outstanding	154.8M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	2.21
EPS	$0.60
Book Value	$1.06
P/E Ratio	37.3x
Price/Sales (TTM)	10.2
Price/Cash Flow (TTM)	36.9x
Operating Margin	29.37%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

TG Therapeutics Inc
NASDAQ:TGTXUnited States

Search Criteria

Charts

Recent News

Sep 18, 2024

DJ TG Therapeutics Price Target Maintained With a $49.00/Share by HC Wainwright & Co., from 1:12PM ET on Wednesday Sep 18, 2024 by Dow Jones

New BRIUMVI(R) (ublituximab-xiiy) Data from the ENHANCE Phase 3b Study Show Rapid 30-Minute Infusions are Well Tolerated in Patients with Relapsing Forms of Multiple Sclerosis, from 7:15AM ET on Wednesday Sep 18, 2024 by Dow Jones

New Data for BRIUMVI(R) (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment, from 7:00AM ET on Wednesday Sep 18, 2024 by Dow Jones

Sep 6, 2024

Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600, from 6:43PM ET on Friday Sep 06, 2024 by Dow Jones

Sep 5, 2024

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting, from 7:30AM ET on Thursday Sep 05, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar